The stock of Humana Inc (NYSE:HUM) is a huge mover today! About 4.13 million shares traded hands or 440.32% up from the average. Humana Inc (NYSE:HUM) has declined 3.74% since March 9, 2016 and is downtrending. It has underperformed by 11.15% the S&P500.
The move comes after 8 months negative chart setup for the $24.53 billion company. It was reported on Oct, 12 by Barchart.com. We have $155.54 PT which if reached, will make NYSE:HUM worth $1.47 billion less.
Analysts await Humana Inc (NYSE:HUM) to report earnings on November, 4. They expect $2.87 earnings per share, up 32.87% or $0.71 from last year’s $2.16 per share. HUM’s profit will be $425.46M for 14.41 P/E if the $2.87 EPS becomes a reality. After $2.30 actual earnings per share reported by Humana Inc for the previous quarter, Wall Street now forecasts 24.78% EPS growth.
Humana Inc (NYSE:HUM) Ratings Coverage
Out of 7 analysts covering Humana (NYSE:HUM), 3 rate it a “Buy”, 0 “Sell”, while 4 “Hold”. This means 43% are positive. Humana has been the topic of 14 analyst reports since July 30, 2015 according to StockzIntelligence Inc. The rating was maintained by Credit Suisse with “Neutral” on Tuesday, August 16. Barclays Capital maintained it with “Equal Weight” rating and $193 target price in Thursday, July 30 report. Jefferies upgraded the stock to “Buy” rating in Monday, July 18 report. The rating was initiated by JP Morgan with “Overweight” on Wednesday, September 16. The rating was initiated by Credit Suisse on Wednesday, December 16 with “Neutral”. Evercore initiated Humana Inc (NYSE:HUM) on Friday, September 23 with “Buy” rating. On Thursday, August 4 the stock rating was maintained by Barclays Capital with “Equal-Weight”. FBR Capital maintained it with “Mkt Perform” rating and $170 target price in Friday, July 22 report. The firm has “Buy” rating given on Thursday, August 4 by Jefferies. The rating was maintained by RBC Capital Markets on Monday, November 9 with “Sector Perform”.
According to Zacks Investment Research, “Humana, Inc. is a health services company that facilitates the delivery of health care services through networks of providers to its medical members. The company’s products are marketed primarily through health maintenance organizations and preferred provider organizations that encourage or require the use of contracted providers. The company also offers various specialty products to employers, including dental, group life and workers’ compensation, and administrative services to those who self-insure their employee health plans.”
Insitutional Activity: The institutional sentiment increased to 1.1 in Q2 2016. Its up 0.10, from 1 in 2016Q1. The ratio improved, as 43 funds sold all Humana Inc shares owned while 172 reduced positions. 59 funds bought stakes while 178 increased positions. They now own 135.64 million shares or 4.91% less from 142.65 million shares in 2016Q1.
Regions Financial Corporation last reported 2,367 shares in the company. The New York-based Hutchin Hill L P has invested 0.16% in Humana Inc (NYSE:HUM). Deere & Com has 0.1% invested in the company for 10,507 shares. Hightower Advsrs Ltd Limited Liability Company has invested 0.03% of its portfolio in Humana Inc (NYSE:HUM). Td Asset, a Ontario – Canada-based fund reported 267,672 shares. Sii Invs Incorporated Wi holds 0.02% or 1,679 shares in its portfolio. Moreover, Signaturefd Ltd has 0.01% invested in Humana Inc (NYSE:HUM) for 198 shares. Next Century Growth Invsts Ltd Liability holds 0.31% or 36,886 shares in its portfolio. Panagora Asset Incorporated has invested 0.01% of its portfolio in Humana Inc (NYSE:HUM). North Star Inv Mgmt holds 100 shares or 0% of its portfolio. Jfs Wealth Advisors Ltd Company accumulated 19 shares or 0% of the stock. Moreover, Argent Trust has 0.12% invested in Humana Inc (NYSE:HUM) for 1,574 shares. Morgan Stanley owns 1.29 million shares or 0.08% of their US portfolio. Next Grp Inc accumulated 0% or 45 shares. First Midwest Comml Bank Trust Division holds 0.22% of its portfolio in Humana Inc (NYSE:HUM) for 9,791 shares.
More notable recent Humana Inc (NYSE:HUM) news were published by: Forbes.com which released: “Humana Becomes Oversold (HUM)” on October 12, 2016, also Forbes.com with their article: “Ex-Div Reminder for Humana (HUM)” published on October 07, 2016, Reuters.com published: “BRIEF-Humana Inc says renewing network agreement with Delaware Valley Acco…” on October 11, 2016. More interesting news about Humana Inc (NYSE:HUM) were released by: Nasdaq.com and their article: “Humana Inc. (HUM) Ex-Dividend Date Scheduled for October 11, 2016” published on October 10, 2016 as well as Bloomberg.com‘s news article titled: “Humana Drops on Declines in Ratings of Medicare Plans” with publication date: October 12, 2016.
HUM Company Profile
Humana Inc. (Humana), incorporated on July 27, 1964, is a health and well-being company. The Company’s medical and specialty insurance products allow members to access healthcare services primarily through its networks of healthcare providers. The Company’s divisions include Retail, Group, Healthcare Services and Other Businesses. The Retail segment consists of Medicare benefits, marketed to individuals or directly via group accounts, as well as individual commercial fully-insured medical and specialty health insurance benefits, including dental, vision, and other supplemental health and financial protection products. The Group segment consists of employer group commercial fully-insured medical and specialty health insurance benefits, including dental, vision, and other supplemental health and voluntary insurance benefits, as well as administrative services only (ASO) products. The Healthcare Services segment includes services offered to its health plan members, as well as to third parties, including pharmacy solutions, well-known provider services, home services and clinical programs, as well as services and capabilities to advance population health. The Other Businesses segment includes its closed-block long-term care insurance policies.
Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.